- Home
- SOGP vs CNSP Comparison
SOGP vs CNSP Comparison
Compare SOGP & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOGP
- CNSP
- Stock Information
- Founded
- SOGP 2010
- CNSP 2017
- Country
- SOGP Singapore
- CNSP United States
- Employees
- SOGP N/A
- CNSP N/A
- Industry
- SOGP
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- SOGP
- CNSP Health Care
- Exchange
- SOGP NYSE
- CNSP Nasdaq
- Market Cap
- SOGP 6.9M
- CNSP 5.6M
- IPO Year
- SOGP 2020
- CNSP 2019
- Fundamental
- Price
- SOGP $4.30
- CNSP $0.84
- Analyst Decision
- SOGP
- CNSP Hold
- Analyst Count
- SOGP 0
- CNSP 1
- Target Price
- SOGP N/A
- CNSP N/A
- AVG Volume (30 Days)
- SOGP 1.9M
- CNSP 228.7K
- Earning Date
- SOGP 07-07-2025
- CNSP 08-13-2025
- Dividend Yield
- SOGP N/A
- CNSP N/A
- EPS Growth
- SOGP N/A
- CNSP N/A
- EPS
- SOGP N/A
- CNSP N/A
- Revenue
- SOGP $278,363,908.00
- CNSP N/A
- Revenue This Year
- SOGP $48.88
- CNSP N/A
- Revenue Next Year
- SOGP N/A
- CNSP N/A
- P/E Ratio
- SOGP N/A
- CNSP N/A
- Revenue Growth
- SOGP N/A
- CNSP N/A
- 52 Week Low
- SOGP $1.18
- CNSP $0.73
- 52 Week High
- SOGP $4.81
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- SOGP 73.35
- CNSP 38.65
- Support Level
- SOGP $3.71
- CNSP $0.73
- Resistance Level
- SOGP $4.48
- CNSP $0.84
- Average True Range (ATR)
- SOGP 0.61
- CNSP 0.07
- MACD
- SOGP 0.27
- CNSP 0.00
- Stochastic Oscillator
- SOGP 84.40
- CNSP 31.47
About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)
Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.